Full Length Research Paper
References
|
Bamba S, Barro-Traoré F, Sawadogo E, Millogo A, Guiguemdé RT (2012). Retrospective study of cases of neuromeningeal cryptococcosis at the University Hospital of BoboDioulasso since accessibility to antiretroviral in Burkina Faso. Journal De Mycologie Medicale 22(1):30-34. |
|
|
Akaihe CL, Nweze EI (2021). Epidemiology of Cryptococcus and cryptococcosis in Western Africa. Mycoses 64(1):4-17. |
|
|
Anglaret X, Minga A, Gabillard D, Ouassa T, Messou E, Morris B, Traore M, Coulibaly A, Freedberg KA, Lewden C, Ménan H (2012). AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire. Clinical Infectious Diseases 54(5):714-723. |
|
|
Aoussi EF, Ehui E, Dembélé JP, Kolia-Diafouka P, Elloh NF, Ouattara SI, Tanon KA, Doumbia A, Adou-Bryn KD, Eholié SP, Bissagnéné E (2012). Cryptoccocal meningitis and HIV in the era of HAART in Ivory Coast. Médecine et Maladies Infectieuses 42(8):349-354. |
|
|
Bedia-Tanoh AV, Kassi KF, Barro-Kiki PCM, Angora KE, Bosson-Vanga AH, Konaté A, Miezan S, Djohan V, Yavo W, Meenan EIH (2018). Cryptococcose neuroméningée à Abidjan. Revue Internationale des Sciences Médicales 20(4):301-305. |
|
|
Bellet V, Kassi FK, Krasteva D, Roger F, Drakulovski P, Mossou C, Kouakou GA, Doumbia A, Delaporte E, Menan H, Bertout S (2021). First report of cryptococcosis due to Cryptococcus gattii sensu stricto VGI in an Ivorian HIV negative patient. Journal of Medical Mycology 31(2):101113. |
|
|
Bicanic T, Harrison TS (2004). Cryptococcal meningitis. British Medical Bulletin 72:99-118. |
|
|
Bissagnéné E, Ouhon J, Kra O, Kadio A (1994). Aspects actuels de la cryptococcose neuroméningée à Abidjan. Médecine et Maladies Infectieuses 24(Suppl2):580-585. |
|
|
Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Nelson KE (1996). Seasonal variation of disseminated Penicillium marneffei infections in Northern Thailand: a clue to the reservoir? Journal of Infectious Diseases 173:1490-1493. |
|
|
Cogliati M, D'Amicis R, Zani A, Montagna MT, Caggiano G, De Giglio O, Balbino S, De Donno A, Serio F, Susever S, Ergin C (2016). Environmental distribution of Cryptococcus neoformans and C. gattii around the Mediterranean basin. FEMS Yeast Research 16(4):fow045. |
|
|
Eholié SP, Adou-Brynh KD, Domoua K, Kakou A (2000). Méningites lymphocytaires non virales de l'adulte à Abidjan (Ivory Coast). Bulletin de la Société de Pathologie Exotique 93:50-54. |
|
|
El Fane M, Badaoui L, Ouladlahsen A, Sodqi M, Marih L, Chakib A, Marhoum El Filali K (2015). La cryptococcose au cours de l'infection à VIH. Journal de Mycologie Medicale25:257-262. |
|
|
Ellabib MS, Aboshkiwa MA, Husien WM, D'Amicis R, Cogliati M (2016). Isolation, Identification and Molecular Typing of Cryptococcus neoformans from pigeon droppings and other environmental sources in Tripoli, Libya. Mycopathologia 181(7-8):603-608. |
|
|
Favalessa OC, Lazera MS, Wanke B, Trilles L, Takahara DT, Tadano T, Dias LB, Vieira AC, Novack GV, Hahn RC (2014). Fatal Cryptococcus gattii genotype AFLP6/VGII infection in a HIV-negative patient: Case report and a literature review. Mycoses 57(10):639-643. |
|
|
Fuge TG, Tsourtos G, Miller ER (2022). Risk factors for late linkage to care and delayed antiretroviral therapy initiation among adults with HIV in sub-Saharan Africa: a systematic review and meta-analyses International Journal of Infectious Diseases 122:885-904. |
|
|
Haas AD, Zaniewski E, Anderegg N, Ford N, Fox MP, Vinikoor M, Dabis F, Nash D, Sinayobye JD, Niyongabo T, Tanon A, Poda A, Adedimeji AA, Edmonds A, Davies MA, Egger M (2018). African regions of the International epidemiologic Databases to Evaluate AIDS (IeDEA). Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes. Journal of the International AIDS Society 21(2):e25084. |
|
|
Qiu J, Olszewski MA, Williamson PR (2013). Cryptococcus neoforman's growth and protection from innate immunity are dependent on expression of a virulence-associated DEAD-Box protein. Vad1 Infection and immunity 81:777-788. |
|
|
Kassi FK, Bellet V, Drakulovski P, Krasteva D, Roger F, Valérie BA, Aboubakar T, Doumbia A, Kouakou GA, Delaporte E, Reynes J, Yavo W, Menan HIE, Bertout S (2018). Comparative typing analyses of clinical and environmental strains of the Cryptococcus neoformans/ Cryptococcus gattii species complex from Ivory Coast. Journal of Medical Microbiology 67(1):87-96. |
|
|
Kidd SE, Chow Y, Mak S, Bach PJ, Chen H, Hingston AO, Kronstad JW, Bartlett KH (2007). Characterization of environmental sources of the human and animal pathogen Cryptococcus gattii in British Columbia, Canada, and the Pacific Northwest of the United States. Applied and Environmental Microbiology 73(5):1433-1443. |
|
|
Kouakou GA, Ello NF, Kassi NA, Keita M, Doumbia A, Mossou C (2017). Fluconazole 1200 mg or 800 mg for cryptococcal meningitis treatment in Ivory Coast. Journal de Mycologie Medicale 27(1):72-78. |
|
|
Kwon-Chung KJ, Fraser JA, Doering TL, Wang Z, Janbon G, Idnurm A, Bahn YS (2014). Cryptococcus neoformans and Cryptococcus gattii, the etiologic agents of cryptococcosis. Cold Spring Harbor Perspectives in Medicine 4(7):a019760. |
|
|
Ministère de la Santé et de la Lutte contre le SIDA Ivory Coast (MSLS, 2015). Plan stratégique national 2016-2020 de lutte contre le SIDA et les infections sexuellement transmissibles. 105p. |
|
|
Moh R, Danel C, Messou E, Ouassa T, Gabillard D, Anzian A, Abo Y, Salamon R, Bissagnene E, Seyler C, Eholié S, Anglaret X. Incidence and determinants of mortality and morbidity following early antiretroviral therapy initiation in HIV-infected adults in West Africa. AIDS 21(18):2483 2491. |
|
|
Nnadi NE, Enweani IB, Cogliati M, Ayanbimpe GM, Okolo MO, Kim E, Sabitu MZ, Criseo G, Romeo O, Scordino F (2016). Molecular characterization of environmental Cryptococcus neoformans VNII isolates in Jos, Plateau State, Nigeria. Journal de Mycologie Medicale 26(4):306-311. |
|
|
Odehouri K, Moreau J (1991). La méningite à cryptocoque à propos de 3 cas. Revue Internationale des Sciences Médicales 290:21-7 |
|
|
Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM (2009). Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23(4):525-530. |
|
|
Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, Denning DW, Loyse A, Boulware DR (2017). Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. The Lancet Infectious Diseases 17(8):873-881. |
|
|
Randhawa HS, Kowshik T, Chowdhary A, Prakash A, Khan ZU, Xu J (2011). Seasonal variations in the prevalence of Cryptococcus neoformans var. grubii and Cryptococcus gattii in decayed wood inside trunk hollows of diverse tree species in north-western India: a retrospective study. Medical Mycology 49(3):320-323. |
|
|
Sodexam (Société d'exploitation et de développement aéroportuaire, aéronautique et météorologique. |
|
|
Sorvillo F, Beall G, Turner PA, Beer VL, Kovacs AA, Kerndt PR (1997) - Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County. AIDS 11:673-679. |
|
|
UNAIDS (2013). UNAIDS Report on the global AIDS epidemic 2013. |
|
|
UNAIDS (2017). Fiche information. Journée Mondiale De Lutte Contre le Sida. |
|
|
UNAIDS (2018). Global HIV & AIDS Statistics (2018). Fact Sheet. |
|
|
UNAIDS Global Report (2023). UNAIDS Report on the global AIDS epidemic 2023. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
